Home / Import refusals / SCS-1717023-7/21/1

SCS-1717023-7/21/1

Baxter Healthcare Corporation — FEI 1417572

Recent inspections

  • 1230610 (NAI Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1171501 (VAI Thu Jun 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067768 (NAI Wed Aug 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988263 (VAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921291 (NAI Fri Apr 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • SCS-7279177-9/11/1 (Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-7393677-9/11/1 (Thu Dec 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-7465202-9/11/1 (Thu Dec 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5925046-3/11/1 (Wed Mar 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-3443210-3/11/1 (Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

Refusal Details

Date
June 15, 2022
Country
United States
Product Category
Drugs and Biologics
Product Code
55RP55 SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT)
Charges
118,3280,75